Analogues for the treatment or prevention of flavivirus infections

Details for Australian Patent Application No. 2010336355 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Liu, Bingcan; Poisson, Carl; Kong, Laval Chan Chun; Das, Sanjoy Kumar; Yannopoulos, Constantin; Cadilhac, Caroline; Reddy, T. Jagadeerswar; Vaiillancourt, Louis; Falardeau, Guy; Pereira, Oswy W.; Bubenik, Monica; Maxwell, John

Agent Davies Collison Cave

Pub. Number AU-A-2010336355

PCT Pub. Number WO2011/079327

Priority 61/316,998 24.03.10 US; 61/290,030 24.12.09 US

Filing date 27 December 2010

Wipo publication date 30 June 2011

International Classifications

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/079327 Priority application(s): WO2011/079327

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010336357-Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer

2010336346-Improved digestion of biosolids in wastewater